Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Peringkat dalam Saham #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Harga Saham
$152.40
Kapitalisasi Pasar
$376.40B
Perubahan (1 hari)
12.48%
Perubahan (1 tahun)
79.44%
Negara
US
Perdagangan Merck & Co., Inc. (MRK)

Kategori

Margin Operasi untuk Merck & Co., Inc. (MRK)
Margin Operasi per August 2026 TTM: 16.65%
Menurut laporan keuangan dan harga saham terbaru dari Merck & Co., Inc., margin operasi saat ini (TTM) adalah 16.65%. Pada akhir 2024, margin operasi perusahaan adalah 31.51%.
Riwayat margin operasi untuk Merck & Co., Inc. dari 2000 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Mengubah
2026 (TTM) 16.65% -59.58%
2025 41.19% 30.72%
2024 31.51% 541.75%
2023 4.91% -84.08%
2022 30.84% 13.80%
2021 27.10% 102.84%
2020 13.36% -34.06%
2019 20.26% -4.07%
2018 21.12% 24.68%
2017 16.94% 22.66%
2016 13.81% -27.73%
2015 19.11% 20.80%
2014 15.82% -9.13%
2013 17.41% -16.70%
2012 20.90% 11.88%
2011 18.68% 155.89%
2010 7.30% -50.20%
2009 14.66% -42.53%
2008 25.51% 9.86%
2007 23.22% 42.54%
2006 16.29% -38.81%
2005 26.62% -9.52%
2004 29.42% -22.80%
2003 38.11% -10.08%
2002 42.38% -3.18%
2001 43.77% 94.36%
2000 22.52% 0.00%
Margin Operasi untuk perusahaan sejenis atau pesaing
Perusahaan Margin Operasi Perbedaan Margin Operasi Negara
43.92% -97.36%
US
26.81% -98.39%
US
29.32% -98.24%
US
26.59% -98.40%
CH
31.24% -98.12%
CH
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.